Estudio WAKE de vida real en pacientes con narcolepsia con cataplejía tratados con pitolisant no respondedores a tratamientos previos

INTRODUCTION. Type 1 narcolepsy is a disabling disease that requires continuous treatment, which is not always effective. Pitolisant is a new drug with a different mechanism of action that offers a new treatment option. The objective of the study was to analyse the effectiveness and safety of pitoli...

Descripción completa

Detalles Bibliográficos
Autores principales: del Río-Villegas, Rafael, Martínez-Orozco, Francisco J., Tomás, Odile Romero-Santo, Cortés, María Yébenes, Gómez-Barrera, Manuel, Gaig-Ventura, Carles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280761/
https://www.ncbi.nlm.nih.gov/pubmed/36169322
http://dx.doi.org/10.33588/rn.7507.2022090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280761/
https://www.ncbi.nlm.nih.gov/pubmed/36169322
http://dx.doi.org/10.33588/rn.7507.2022090

Ejemplares similares